欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0525/001
药品名称
Votum plus 20 mg/12,5 mg
活性成分
hydrochlorothiazide 12.5 mg
olmesartan medoxomil 20.0 mg
剂型
Film-coated tablet
上市许可持有人
Berlin-Chemie AG Glienicker Weg 125 12489 Berlin Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Belgium (BE)
Luxembourg (LU)
Ireland (IE)
Austria (AT)
Mencord Plus 20 mg/12,5 mg - Filmtabletten
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Poland (PL)
Revival Plus
Latvia (LV)
Mesar Plus 20/12,5 mg apvalkotās tabletes
Lithuania (LT)
Mesar plus 20 mg/12,5 mg plėvele dengtos tabletės
Estonia (EE)
Hungary (HU)
Laresin Plus 20/12,5mg filmtabletta
Cyprus (CY)
Olartan plus 20/12.5mg tablets
Czechia (CZ)
Slovakia (SK)
Tenzar plus 20/12,5
Slovenia (SI)
Malta (MT)
许可日期
2005/09/28
最近更新日期
2024/04/02
药物ATC编码
C09DA08 olmesartan medoxomil and diuretics
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Fixed Combination [Article 10.1.(b)]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
final_common_spc_20_0525_082
Date of last change:2023/05/24
Final PL
|
common-pl-olmhct20_clean
Date of last change:2021/07/12
Final PL
|
common-pl-olmhct40 clean
Date of last change:2021/07/12
Final PL
|
common-pl-olmhct20_rev
Date of last change:2021/07/12
Final PL
|
common-pl-olmhct40 rev
Date of last change:2021/07/12
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase